Stocks opened lower with the early weakness attributed to profit taking after the market’s most recent run-up. There was little in the way of a catalyst as the economic calendar had little scheduled and the earnings season is beginning to wind down. Investors appeared to be more interested on whether the U.S. would be pulling out of the Iranian nuclear deal that was signed by President Obama four years ago. President Trump’s decision to withdraw was announced in an afternoon speech and the knee-jerk reaction by investors was to sell stocks and push the market to session lows. The market rebounded from there to close mixed and little changed. ECONOMIC EVENTS: In the U.S., the JOLTS report showed job openings climbed 472,000 to a record 6.55M in March. In China, trade numbers were strong, with exports rising 12.9% in April and imports up 21.5%, both of which topped expectations. In White House news, President Trump announced that the U.S. will withdraw from the Iran Nuclear Deal. The President noted in his address on the matter that Secretary of State Mike Pompeo is en route to North Korea to prepare for the meeting between the two countries’ leaders. COMPANY NEWS: Reuters reported that Comcast (CMCSA) is talking to investment banks about getting bridge financing for an all-cash bid to displace Disney (DIS) on its $52B deal to purchase most of 21st Century Fox’s (FOXA) assets. According to the report, Comcast only plans to proceed with a bid for Fox if a federal judge allows AT&T’s (T) planned acquisition of Time Warner (TWX) to proceed… Valeant (VRX) rose 9% after the company reported better than expected first quarter revenue and raised its FY18 outlook. The drug and medical supply maker also announced that it will change its name to Bausch Health Companies, effective in July, with CEO Joe Papa calling the plan “a major step forward” in the company’s “transformation”… Meanwhile, Mylan (MYL) shares fell 2% after Bloomberg reported that a patient advocacy group said EpiPens are in short supply following manufacturing issues. The U.S. Food and Drug Administration has not added the device to its list of medications in shortage, according to Bloomberg. Reuters later reported, however, that Mylan said it is currently receiving a continual supply of EpiPens from manufacturing partner Meridian Medical. MAJOR MOVERS: Among the noteworthy gainers was Nevsun Resources (NSU), which rose 16% after its board unanimously rejected a non-binding unsolicited proposal led by Euro Sun Mining and Lundin Mining. Also higher were Fiesta Restaurant (FRGI) and Trex (TREX), which gained a respective 13% and 11% after reporting quarterly results. Among the notable losers was Akcea Therapeutics (AKCA), which fell 13% after an FDA briefing document discussed the “safety concerns” of volanesorsen ahead of an upcoming panel review of the drug. Also lower was Hertz (HTZ), which declined 19% after reporting quarterly results. INDEXES: The Dow gained 2.89, or 0.01%, to 24,360.21, the Nasdaq rose 1.69, or 0.02%, to 7,266.90, and the S&P 500 declined 0.71, or 0.03%, to 2,671.92.